147 related articles for article (PubMed ID: 6700599)
1. [Determination of fibrin-fibrinogen degradation products in the serum of newborn infants using a standardized hemagglutination inhibition test (the FDP kit)].
Weitzel KH; Eschenbach C
Monatsschr Kinderheilkd; 1984 Jan; 132(1):23-8. PubMed ID: 6700599
[TBL] [Abstract][Full Text] [Related]
2. Comparisons of hemagglutination inhibition, staphylococcal clumping, and latex agglutination tests for canine fibrinolytic degradation products.
Chen JP; Williams TK; Legendre AM
Am J Vet Res; 1981 Dec; 42(12):2049-52. PubMed ID: 7340573
[TBL] [Abstract][Full Text] [Related]
3. Comparison of a direct latex-agglutination technic with the tanned red cell hemagglutination inhibition immunoassay (TRCHII) for semiquantitation of fibrinogen/fibrin degradation products.
Wilson JE; Thornton RD
Am J Clin Pathol; 1976 Apr; 65(4):528-32. PubMed ID: 1266814
[TBL] [Abstract][Full Text] [Related]
4. Fibrinogen-fibrin degradation products: hemagglutination inhibition immunoassay in plasma.
Chi DS; Chen JP
Tex Rep Biol Med; 1975; 33(4):493-508. PubMed ID: 133472
[TBL] [Abstract][Full Text] [Related]
5. Comparative sensitivity of two hemagglutination inhibition immunoassays for fibrinolytic degradation products in human serum.
Chi DS; Chen JP
Thromb Haemost; 1976 Apr; 35(2):423-36. PubMed ID: 823661
[TBL] [Abstract][Full Text] [Related]
6. Evaluation of two new assays for determination of serum fibrinogen/fibrin degradation products.
Sumner K; Feller E; Galanakis DK; Mosesson MW
Ann Clin Lab Sci; 1979; 9(5):362-7. PubMed ID: 533231
[TBL] [Abstract][Full Text] [Related]
7. [Differential determination of fibrinogen degradation products in assessment of the stages of plasma consumption in patients with infection and liver cirrhosis].
Raschka C; Róka L
Leber Magen Darm; 1993 Jan; 23(1):31-4. PubMed ID: 8445974
[TBL] [Abstract][Full Text] [Related]
8. Unreliability of current serum fibrin degradation product (FDP) assays.
Gaffney PJ; Perry MJ
Thromb Haemost; 1985 Jun; 53(3):301-2. PubMed ID: 3901388
[TBL] [Abstract][Full Text] [Related]
9. [Quantitative evaluation of fibrinogen-fibrin degradation products (FDP) in the blood of full-term newborn infants, using the staphylococcal clumping test].
Schettini F; Altomare M; Mautone A
Boll Soc Ital Biol Sper; 1976 Feb; 52(3):121-6. PubMed ID: 949391
[No Abstract] [Full Text] [Related]
10. [Possibilities of using immunoenzyme test systems for determining levels of myoglobin, fibrinogen, fibrin-fibrinogen degradation products and fibronectin in the diagnosis of somatic diseases].
Ermolin GA; Shelepova TM; Dikov MM; Osmanov SK; Voloshchuk OM
Biull Vsesoiuznogo Kardiol Nauchn Tsentra AMN SSSR; 1987; 10(1):33-7. PubMed ID: 3300700
[TBL] [Abstract][Full Text] [Related]
11. [Effect of fibrin-fibrinogenolysis on the determination of the fibrinogen content and fibrin-fibrinogen degradation products (FDP) by means of the fibrin polymerization time (FPT test)].
Vorlová Z; Dyr IE
Folia Haematol Int Mag Klin Morphol Blutforsch; 1979; 106(5-6):967-70. PubMed ID: 94893
[No Abstract] [Full Text] [Related]
12. Tanned red cell haemagglutination-inhibition immunoassay of fibrinogen-fibrin degradation products.
Kings GL; Stoodley KD
Med Lab Sci; 1980 Oct; 37(4):317-22. PubMed ID: 7207041
[No Abstract] [Full Text] [Related]
13. Fibrinogen degradation products in acute renal failure of the newborn.
Assadi F; Delivoria-Papadopoulos M; Pereira G; Peckham G; Norman M
Clin Nephrol; 1983 Feb; 19(2):74-81. PubMed ID: 6839555
[TBL] [Abstract][Full Text] [Related]
14. [Signification of fibrinogen degradation (FDP) product in CSF during the neonatal period (author's transl)].
Dalens B; Bezou MJ; Coulet M; Raynaud EJ
Pathol Biol (Paris); 1981 Dec; 29(10):605-8. PubMed ID: 7041056
[TBL] [Abstract][Full Text] [Related]
15. False-negative test for fibrinogen--fibrin degradation products.
Kickler T; Bell WR
Am J Clin Pathol; 1977 Jul; 68(1):78-80. PubMed ID: 868807
[TBL] [Abstract][Full Text] [Related]
16. [Study of the fibrin degradation products in the synovial fluid of rheumatological diseases (author's transl)].
Kolodie L; Phelipp X; Baccard C
Sem Hop; 1980 May 8-15; 56(17-18):832-6. PubMed ID: 6248965
[TBL] [Abstract][Full Text] [Related]
17. [Persistent discrepancy between FDP and D-dimer in a patient with acute leukemia].
Sato N; Takahashi H; Nikuni K; Seki Y; Wada K; Tatewaki W; Shibata A
Rinsho Ketsueki; 1995 Mar; 36(3):212-7. PubMed ID: 7783324
[TBL] [Abstract][Full Text] [Related]
18. Serum fibrinogen/fibrin degradation products in patients with ovarian carcinoma.
Lalos O; Frankendal B; Rudolphi O
Ann Chir Gynaecol; 1977; 66(3):131-134. PubMed ID: 327909
[TBL] [Abstract][Full Text] [Related]
19. [Immunological assay and radioimmunoassay of FDP on human serum (author's transl)].
Abe K
Rinsho Byori; 1978; 26(4):313-21. PubMed ID: 671777
[No Abstract] [Full Text] [Related]
20. [Clinical significance of a new fibrinogen/fibrin degradation products(FDP) test using plasma samples for the diagnosis of fibrinogenolysis and fibrinolysis].
Imoto K; Yasumuro Y; Taki M; Suzuki N; Tanabe H; Ichikawa Y
Rinsho Byori; 2001 Mar; 49(3):283-9. PubMed ID: 11307330
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
